Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Express Scripts
US Department of Justice
Farmers Insurance
US Army

Generated: October 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 050612

« Back to Dashboard

NDA 050612 describes PRED-G, which is a drug marketed by Allergan and is included in two NDAs. It is available from one supplier. Additional details are available on the PRED-G profile page.

The generic ingredient in PRED-G is gentamicin sulfate; prednisolone acetate. There are fifteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the gentamicin sulfate; prednisolone acetate profile page.
Summary for 050612
Ingredient:gentamicin sulfate; prednisolone acetate
Pharmacology for NDA: 050612
Suppliers and Packaging for NDA: 050612
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PRED-G gentamicin sulfate; prednisolone acetate OINTMENT;OPHTHALMIC 050612 NDA Allergan, Inc. 0023-0066 0023-0066-04 1 TUBE in 1 CARTON (0023-0066-04) > 3.5 g in 1 TUBE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:OINTMENT;OPHTHALMICStrengthEQ 0.3% BASE;0.6%
Approval Date:Dec 1, 1989TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.